Annual Nordic Lymphoma Group plenary meeting November 9 - 10, 2016 Bella Sky - Copenhagen – Denmark Meeting room: 180+181

Dear colleagues and sponsors

It is a pleasure to welcome you to the annual Nordic Lymphoma Group plenary meeting.

We wish you all very welcome to Copenhagen!

On behalf of the Coordinating group of the Nordic Lymphoma Group Peter Brown

The meeting is sponsored by:

Annual Nordic Lymphoma Group plenary meeting November 9 - 10, 2016 Bella Sky - Copenhagen – Denmark Meeting room: 180+181 Wednesday 9.11.2016 12.00-13.00 Registration outside meeting room 180+181 and lunch in restaurant BM

Session I (Chaired by Peter Brown) 13.00-14.30 Free papers 14.30-15.30 Invited speaker: Dr Peter Dreger, Heidelberg University hospital: Allo-transplantation in lymphoma: Does it still have a role?

15.30-16.00 Coffee break

Session II (Chaired by Mats Jerkeman) 16.00-16.30 Large Cell Group, Sirpa Leppä, Helsinki 16.30-17.00 T-Cell group, Francesco d’Amore, Århus 17.00-17.30 Mantle cell group, Mats Jerkeman, Lund 17.30-18.00 CNS-Group, Elisa Jacobsen-Pulczynski, Århus 18.00-18.30 Business meeting 19.30 Dinner at the venue at Restaurant Treehouse

Thursday 10.11.2016 Session III (Chaired by Stefan Norin) 9.00-10.00 Interesting cases

10.00-10.30 Coffee break

Session IV (Chaired by Arne Kolstad) 10.30-12.00 Educational session “Controversies in treatment of DLBCL lymphoma” 1: Double hit: Outi Kuittinen 2: PET positive residual disease (DLBCL): Sirkku Jyrkkiö 3: RT after Chemoterapy: Bjørn Østenstad 4: CNS involvement of DLBCL: Mats Jerkeman

12.00-13.00 Lunch in restaurant BM

Session V (Chaired by Elisa Pulczynski) 13.00-13.30 Indolent group, Bjørn Østenstad, Oslo 13.30-13.50 Hodgkin group, Alexander Fosså, Oslo 13.50-14.15 Epidemiology Group, Karin Ekström-Smedby, Stockholm 14.15-14.30 PTLD Group, Maja Vase, Århus 14.30-15.00 Pathology group, Marja-Liisa Karjalainen-Lindsberg, Helsinki 15.00 Farewell Annual Nordic Lymphoma Group plenary meeting November 9 - 10, 2016 Bella Sky - Copenhagen – Denmark Meeting room: 180+181

List of delegates: First Name Last Name Hospital/Company Country Alexandra Lindblad Skåne University Hospital Sweden Andreas Hermansen Takeda Norway Norway Anette Hommelgaard Gilead Sciences Denmark Denmark Anna Sivula Takeda Oy Finland Oslo Universitetssykehus, Anne Kirsti Blystad Radiumhospitalet Norway Anne Turid Bjørnevik Haukeland Universitetssjukehus Norway Anne-Mari Engstrom Bristol Myers Squibb Sweden Annika Pasanen HUCH Cancer Center Finland Annikki Aromaa-Häyhä KUH Kuopio University Hospital Finland Arian Sadeghi Gilead Sciences Sweden Arne Grondal Celgene AS Norway Arne Kolstad Oslo University Hospital Norway Bendt Nielsen Aarhus University Hospital Denmark Bente Lentz Abbvie A/S Denmark Betinna Christiansen Celgene ApS Denmark Birgitta Sander Karolinska University Hospital Sweden Birgitte Eiken Sykehuset Østfold Kalnes - Norway Norway Bjørn Østenstad Oslo university hospital, Radiumhospitalet Norway Björn Wahlin Karolinska University Hospital Sweden Britt Kjersti Lund Celgene AS Norway Camilla Herstedt Celgene AB Sweden Cecilie Hoxmark Bms Norway Chloe Steen Oslo University Hospital Norway Christian Eskelund Rigshospitalet Denmark Daniel Molin Akademiska sjukhuset Sweden Daniel Tesfa Roche Denmark David Erixon Sundsvall county hospital Sweden Dlawer Abdulla Barzenje Ostfold Hospital Trust Norway Dorte Tholstrup Sjællands Universitetshospital Roskilde Denmark Elisa Pulczynski Aarhus University Hospital Denmark Elisabet Oladottir Roche a/s Denmark Elisabeth Birkdal Koba Takeda Pharma AB Sweden Elisabeth Szekely University Hospital, Malmö Denmark Emma-Leena Alarmo Takeda Oy Finland Esa Kari Oulu University Hospital Finland Eva Horney Central Hospital of Kristianstad Sweden Eva Kimby Karolinska Sweden Florentin Späth Norrlands University Hospital Umeå Sweden Annual Nordic Lymphoma Group plenary meeting November 9 - 10, 2016 Bella Sky - Copenhagen – Denmark Meeting room: 180+181 Francesco Damore Aarhus University Hospitalb Denmark Fredrik Ellin Kalmar County Hospital Sweden Git Jansson Celgene AB Sweden The Norwegian Radium Hospital Grete Lauritzsen Oslo University Hospital Norway Hanne Kuitunen Oulu University Hospital Finland Harald Holte Oslo University Hospital Norway Hardee Sabir Sjællands universitetshospital Denmark Heidi Kristiansen Roche Norway Heli Lehtonen Roche Oy Finland Helle Toldbod Aarhus University Hospital Denmark Henrik Cederleuf Skåne University Hospital, Lund Sweden Section of Hematology and Coagulation Herman Nilsson-Ehle Sahlgrenska University Hospital Sweden Hoa Tran Akershus University Hospital Norway Håkon Hov St. Olavs Hospital Norway Ida Sillesen Aarhus University Hospital Denmark Ingrid Glimelius Uppsala Akademiska Sjukhus Sweden Irma Petruskevicius Aarhus University Hospital Denmark Jakob Madsen Aalborg Universitetshospital Denmark James Gibson CTI Life Sciences United Kingdom Jeanette Glad Roche a/s Denmark Jenny Cajnerud Skala Janssen Oncology Sweden Jillian Wise Oslo University Hospital Norway Johan Linderoth Lund University Hospital Sweden Judit Jørgensen Aarhus University Hospital Denmark Jürgen Rolke Sørlandet sykehus Kristiansand Norway Kaisa Tammenmaa Sanofi Genzyme Finland Karin Ekström Smedby Karolinska Sweden Karin Fjordén Skåne University Hospital, Lund Sweden Karin Papworth NUS Sweden Karin Wader St Olavs Hospital Trondheim Norway Norway Katarina Nordling Sanofi Genzyme Sweden Katja Marin Kuopio University Hospital Finland Kirsten Wind Aarhus University Hospital Denmark Klaus Beiske Oslo University Hospital Radiumhospitalet Denmark Knut Steffensen Takeda Norway Kristina Drott Skåne University Hospital Sweden Lars Helgeland Haukeland University Hospital Norway Lasse Nielsen Janssen DK Denmark Lena Brandefors Sunderby sjukhus Sweden Helsinki University Hospital Leo Meriranta Comprehensive Cancer Center Finland Annual Nordic Lymphoma Group plenary meeting November 9 - 10, 2016 Bella Sky - Copenhagen – Denmark Meeting room: 180+181 Linda Wiman Celgene AB Sweden Lise Nielsen Aarhus University Hospital Denmark Magnus Lövenklev Takeda Pharma AB Sweden Magnus Moksnes Oslo University Hospital Norway Maja Vase Aarhus University Hospital Denmark Maria Holmqvist AbbVie Denmark Oslo Universiy Hospital Marianne Brodtkorb the Norwegian Radium Hospital Norway Marit Rinde Sykehuset i Vestfold, Tønsberg Norway Karjalainen- Marja-Liisa Lindsberg HUCH Finland Marjukka Pollari Tampere University Hospital Finland Marlene Mozart Janssen Cilag AB Denmark Martin Erlanson Umeå University Hospital Sweden

Helsinki University Hospital Matias Autio Comprehensive Cancer Center Finland Mats Jerkeman Skåne University Hospital Sweden Mette Mardell løwert Gilead Denmark Mette Pedersen Department of Pathology, Herlev Hospital Denmark Michael Clausen Aarhus University Hospital Denmark Mikael Olsson Hallands Sjukhus Varberg Sweden Nevzeta Kuric Medicinkliniken Sweden Outi Kuittinen Oulu University Hospital Finland Paw Jensen Aalborg University Hospital Denmark Pekka Varis Roche Finland Finland Pernille Lyngholm-Kjaerby Takeda Denmark Pernille Normann Amgen Denmark Pertti Paavola Bristol-Myers Squibb Finland Finland Peter Brown Rigshospitalet Denmark Peter Fernegard Celgene Sweden Peter Kamper Aarhus University Hospital Denmark Peter Meyer Stavanger University Hospital Norway Peter Nørgaard Dept. of Pathology, Herlev Hospital Denmark Philipp Treskes CTI LifeSciences Germany Pia Suonpää Helsinki University Hospital Finland Helsinki University Hospital Riikka Räty Cancer Comprehensive Center Finland Roosa Prusila University of Oulu Finland Saeeda Rana Roche Norge AS Norway Samuli Vaittinen Turku University Hospital Finland Sandra Lockmer Karolinska University Hospital Sweden Sanna Saariaho Celgene Oy Finland Simon Husby Rigshospitalet Denmark Annual Nordic Lymphoma Group plenary meeting November 9 - 10, 2016 Bella Sky - Copenhagen – Denmark Meeting room: 180+181 Sirkku Jyrkkiö Turku University Central Hospital Finland Sirpa Leppä Helsinki University Hospital Finland Stefan Norin Karolinska University Hospital Sweden Stephanie Serre BMS Denmark Susanna Mannisto HUCH Cancer Center Finland Susanna Tokola Oulu University Hospital Finland Svend Jørgensen AbbVie Denmark Tarec El-Galaly Aalborg Denmark Thomas Larsen Odense University Hospital Denmark Thomas Relander Dept of Hematolgy and oncology Sweden Unn-Merete Fagerli St Olavs Hospital Norway Haukeland University Hospital Øystein Fluge Dept. of Oncology Norway